Korea should protect national interest in pharmaceuticals

Published: 2007-03-15 06:56:00

Updated: 2007-03-15 06:56:00

The eighth round of Korea-U.S. free trade agreement (FTA) talks ended on March 12, but analysts say the negotiators are only just entering the "real bargaining" stage since core issues still remain unresolved.

Trade ministers and ranking agricultural officials from the two countries will try t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK